drugset / Trial / NCT03984370
Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass
RandomizedCrossoverDouble-blindTreatment
Summary
The aim of this study is investigating the effect of a novel glucagon analogue administration in gastric bypass operated individuals, who are reactive hypoglycemic.
Timeline
- Start
- 2019-09-18
- Primary completion
- 2020-02-26
- Completion
- 2020-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dasiglucagon | Peptide | 80 ug | Subcutaneous |
| Subject | Dasiglucagon | Peptide | 200 ug | Subcutaneous |